302 related articles for article (PubMed ID: 38474604)
1. Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules.
Almatroodi SA; Almatroudi A; Alharbi HOA; Khan AA; Rahmani AH
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474604
[TBL] [Abstract][Full Text] [Related]
2. MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
Wu HT; Liu YE; Hsu KW; Wang YF; Chan YC; Chen Y; Chen DR
Am J Chin Med; 2020; 48(5):1221-1241. PubMed ID: 32668964
[TBL] [Abstract][Full Text] [Related]
3. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Yao X; Jiang W; Yu D; Yan Z
Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
[TBL] [Abstract][Full Text] [Related]
4. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells.
Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH
BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172
[TBL] [Abstract][Full Text] [Related]
5. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
[TBL] [Abstract][Full Text] [Related]
6. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of luteolin on the human gastric cancer cell line MKN45 and underlying mechanism.
Yajie D; Feng L; Zhaoyan LI; Yan X; Nida C; Guangao Z; Rui W; Aiguang Z
J Tradit Chin Med; 2023 Feb; 43(1):34-41. PubMed ID: 36639993
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
9. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
[TBL] [Abstract][Full Text] [Related]
10. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
11. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways.
Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X
Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688
[TBL] [Abstract][Full Text] [Related]
12. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pratheeshkumar P; Son YO; Budhraja A; Wang X; Ding S; Wang L; Hitron A; Lee JC; Kim D; Divya SP; Chen G; Zhang Z; Luo J; Shi X
PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633
[TBL] [Abstract][Full Text] [Related]
13. Luteolin Inhibits Proliferation and Induces Apoptosis of Human Placental Choriocarcinoma Cells by Blocking the PI3K/AKT Pathway and Regulating Sterol Regulatory Element Binding Protein Activity.
Lim W; Yang C; Bazer FW; Song G
Biol Reprod; 2016 Oct; 95(4):82. PubMed ID: 27580988
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z
Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356
[TBL] [Abstract][Full Text] [Related]
15. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
Zhang XJ; Jia SS
Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
[TBL] [Abstract][Full Text] [Related]
16. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
17. Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway.
Iida K; Naiki T; Naiki-Ito A; Suzuki S; Kato H; Nozaki S; Nagai T; Etani T; Nagayasu Y; Ando R; Kawai N; Yasui T; Takahashi S
Cancer Sci; 2020 Apr; 111(4):1165-1179. PubMed ID: 31994822
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits angiotensin II-induced human umbilical vein endothelial cell proliferation and migration through downregulation of Src and Akt phosphorylation.
Zhu M; Chen D; Li D; Ding H; Zhang T; Xu T; Zhang Y
Circ J; 2013; 77(3):772-9. PubMed ID: 23171663
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
Chen YF; Wu S; Li X; Chen M; Liao HF
Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
[TBL] [Abstract][Full Text] [Related]
20. Luteolin-7-O-glucoside inhibits cell proliferation and modulates apoptosis through the AKT signaling pathway in human nasopharyngeal carcinoma.
Ho HY; Chen PJ; Lo YS; Lin CC; Chuang YC; Hsieh MJ; Chen MK
Environ Toxicol; 2021 Oct; 36(10):2013-2024. PubMed ID: 34165247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
